Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Healthtrust
Julphar
Argus Health
McKesson
Express Scripts
Cantor Fitzgerald
Merck
Fuji

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021191

« Back to Dashboard

NDA 021191 describes IMAGENT, which is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs. Additional details are available on the IMAGENT profile page.

The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.

Summary for 021191

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INTRAVENOUSStrength0.92MG/VIAL;0.092MG/VIAL
Approval Date:May 31, 2002TE:RLD:No

Expired Orange Book Patents for NDA: 021191

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
Vesselon Spv LlcIMAGENTdimyristoyl lecithin; perflexaneINJECTABLE;INTRAVENOUS021191-001May 31, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Baxter
Mallinckrodt
Covington
Boehringer Ingelheim
Fish and Richardson
Deloitte
McKinsey
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot